CS logo
small CS logo
Center For Oncology Research & Treatment, P.A.

Dallas, Texas, United States

About Center For Oncology Research & Treatment, P.A.


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials

Clinical Trials at Center For Oncology Research & Treatment, P.A.


During the past decade, Center For Oncology Research & Treatment, P.A. conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 YearsStarted TrialsCompleted Trails
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
An Investigational Drug (CAL) Versus Zoledronic Acid (Zometa®) in Patients With Breast Cancer
Completed
Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Previously Treated Metastatic Colorectal Cancer
2003-01-01
2007-01-01
Completed
855
Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Metastatic Colorectal Cancer.
2003-02-01
Completed
1,168
A Multiple Myeloma Trial in Patients With Bone Metastases
2004-10-01
2007-10-01
Completed
179
Docetaxel in Combination With GVAX ® Immunotherapy Versus Docetaxel and Prednisone in Prostate Cancer Patients
2005-07-01
2009-06-01
Terminated
408
A Companion Study for Patients Enrolled in Prior/Parent Ipilimumab Studies
2006-05-01
2014-04-01
Completed
248
Study of Ipilimumab (MDX-010) Monotherapy in Patients With Previously Treated Unresectable Stage III or IV Melanoma
2006-04-01
2007-07-01
Completed
210
Efficacy Study of Ipilimumab Versus Placebo to Prevent Recurrence After Complete Resection of High Risk Stage III Melanoma
2008-06-30
2018-11-26
Completed
1,211

Rows per page:

1–9 of 9

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Center For Oncology Research & Treatment, P.A." #1 sponsor was "Bristol-Myers Squibb" with 4 trials, followed by "Novartis Pharmaceuticals" with 2 trials sponsored, "Cell Genesys" with 1 trials sponsored, "Chugai Pharma USA" with 1 trials sponsored and "Novartis" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Center For Oncology Research & Treatment, P.A." #1 collaborator was "Bayer" with 2 trials as a collaborator and "Medarex" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.
Created with Highcharts 11.1.0Top Leading Sponsors

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at Center For Oncology Research & Treatment, P.A.


According to Clinical.Site data, the most researched conditions in "Center For Oncology Research & Treatment, P.A." are "Colonic Neoplasms" (2 trials), "Colorectal Neoplasms" (2 trials), "Melanoma" (2 trials), "Prostate Cancer" (2 trials) and "Rectal Neoplasms" (2 trials). Many other conditions were trialed in "Center For Oncology Research & Treatment, P.A." in a lesser frequency.

Clinical Trials Intervention Types at Center For Oncology Research & Treatment, P.A.


Most popular intervention types in "Center For Oncology Research & Treatment, P.A." are "Drug" (9 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Ipilimumab" (3 trials), "Placebo" (2 trials), "Vatalanib" (2 trials), "CAL" (1 trials) and "Chemotherapy (docetaxel and prednisone)" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Center For Oncology Research & Treatment, P.A.


The vast majority of trials in "Center For Oncology Research & Treatment, P.A." are 6 trials for "All" genders, 2 trials for "Male" genders and 1 trials for "Female" genders.

Clinical Trials Status at Center For Oncology Research & Treatment, P.A.


Currently, there are NaN active trials in "Center For Oncology Research & Treatment, P.A.". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Center For Oncology Research & Treatment, P.A., undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Center For Oncology Research & Treatment, P.A., 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By Phase

Created with Highcharts 11.1.0Trials Status